273
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Triglyceride-Glucose Index and Serum Uric Acid Levels: A Biochemical Study on Anthropometry in Non-Obese Type 2 Diabetes Mellitus Patients

, ORCID Icon, ORCID Icon, , ORCID Icon, , & show all
Pages 3447-3458 | Received 29 Aug 2022, Accepted 20 Oct 2022, Published online: 03 Nov 2022

References

  • Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380–390. doi:10.1038/s41584-020-0441-1
  • Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
  • Song P, Wang H, Xia W, et al. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Sci Rep. 2018;8(1):4314. doi:10.1038/s41598-018-22570-9
  • Donkeng M, Kuate D, Koudjou PN, Noubiap JJ, Kuiate JR. Association between hyperuricemia and glycated hemoglobin in type 2 diabetes at the District Hospital of Dschang. Pan Afr Med J. 2021;40:177. doi:10.11604/pamj.2021.40.177.30207
  • Yu KH, Chen DY, Chen JH, et al. Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan. Int J Rheum Dis. 2018;21(4):772–787. doi:10.1111/1756-185X.13266
  • Woyesa SB, Hirigo AT, Wube TB. Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocr Disord. 2017;17(1):76. doi:10.1186/s12902-017-0226-y
  • Kimura Y, Tsukui D, Kono H. Uric acid in inflammation and the pathogenesis of atherosclerosis. Int J Mol Sci. 2021;22(22):12394. doi:10.3390/ijms222212394
  • Li ZY, Liu B, Ji Y, et al. 2型糖尿病患者血尿酸水平与超敏C反应蛋白的关系 [Association between serum uric acid levels and high sensitive C-reactive protein in patients with type 2 diabetes]. Zhonghua Yi Xue Za Zhi. 2017;97(28):2181–2185. Chinese. doi:10.3760/cma.j.issn.0376-2491.2017.28.005
  • Scheithauer TPM, Rampanelli E, Nieuwdorp M, et al. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020;11:571731. doi:10.3389/fimmu.2020.571731
  • Wan X, Xu C, Lin Y, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925–932. doi:10.1016/j.jhep.2015.11.022
  • Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22(17):9221. doi:10.3390/ijms22179221
  • Han T, Meng X, Shan R, et al. Temporal relationship between hyperuricemia and obesity, and its association with future risk of type 2 diabetes. Int J Obes. 2018;42(7):1336–1344. doi:10.1038/s41366-018-0074-5
  • Arersa KK, Wondimnew T, Welde M, Husen TM. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients attending Jimma Medical Center, Southwestern Ethiopia, 2019. Diabetes Metab Syndr Obes. 2020;13:2059–2067. doi:10.2147/DMSO.S252825
  • Binh TQ, Tran Phuong P, Thanh Chung N, et al. First report on association of hyperuricemia with type 2 diabetes in a Vietnamese population. Int J Endocrinol. 2019;2019:5275071. doi:10.1155/2019/5275071
  • Elizalde-Barrera CI, Estrada-Garcia T, Lozano-Nuevo JJ, et al. Serum uric acid levels are associated with homeostasis model assessment in obese nondiabetic patients: HOMA and uric acid. Ther Adv Endocrinol Metab. 2017;8(10):141–146. doi:10.1177/2042018817732731
  • Gu Q, Hu X, Meng J, et al. Associations of triglyceride-glucose index and its derivatives with hyperuricemia risk: a cohort study in Chinese general population. Int J Endocrinol. 2020;2020:3214716. doi:10.1155/2020/3214716
  • Yoo TW, Sung KC, Shin HS, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69(8):928–933. doi:10.1253/circj.69.928
  • Xu YL, Xu KF, Bai JL, et al. Elevation of serum uric acid and incidence of type 2 diabetes: a systematic review and meta-analysis. Chronic Dis Transl Med. 2016;2(2):81–91. doi:10.1016/j.cdtm.2016.09.003
  • Banik SD, Avila-Nava A, Lugo R, Chim Ake R, Gutierrez Solis AL. Association between low-grade inflammation and hyperuricemia in adults with metabolic syndrome in Yucatan, Mexico. Can J Diabetes. 2022;46(4):369–374. doi:10.1016/j.jcjd.2021.11.010
  • Zhao H, Lu J, He F, et al. Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation. Front Immunol. 2022;13:931087. doi:10.3389/fimmu.2022.931087
  • Zhang X, Nie Q, Zhang Z, et al. Resveratrol affects the expression of uric acid transporter by improving inflammation. Mol Med Rep. 2021;24(2):1–9.
  • Liu XZ, Chen DS, Xu X, et al. Longitudinal associations between metabolic score for visceral fat and hyperuricemia in non-obese adults. Nutr Metab Cardiovasc Dis. 2020;30(10):1751–1757. doi:10.1016/j.numecd.2020.06.001
  • Shirasawa T, Ochiai H, Yoshimoto T, et al. Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan. BMC Endocr Disord. 2020;20(1):2. doi:10.1186/s12902-019-0481-1
  • Yang C, Yang S, Xu W, et al. Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: a retrospective cohort study. PLoS One. 2017;12(5):e0177249. doi:10.1371/journal.pone.0177249
  • Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. doi:10.1089/met.2008.0034
  • Guerrero-Romero F, Villalobos-Molina R, Jimenez-Flores JR, et al. Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults. Arch Med Res. 2016;47(5):382–387. doi:10.1016/j.arcmed.2016.08.012
  • Kang B, Yang Y, Lee EY, et al. Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents. Int J Obes. 2017;41(5):789–792. doi:10.1038/ijo.2017.14
  • Pan Y, Zhong S, Zhou K, et al. Association between diabetes complications and the triglyceride-glucose index in hospitalized patients with type 2 diabetes. J Diabetes Res. 2021;2021:8757996. doi:10.1155/2021/8757996
  • Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort. Transl Res. 2021;228:42–51. doi:10.1016/j.trsl.2020.08.003
  • Zheng R, Mao Y. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis. 2017;16(1):175. doi:10.1186/s12944-017-0562-y
  • Shi W, Xing L, Jing L, Tian Y, Liu S. Usefulness of triglyceride-glucose index for estimating hyperuricemia risk: insights from a general population. Postgrad Med. 2019;131(5):348–356. doi:10.1080/00325481.2019.1624581
  • Liu XZ, Xu X, Zhu JQ, Zhao DB. Association between three non-insulin-based indexes of insulin resistance and hyperuricemia. Clin Rheumatol. 2019;38(11):3227–3233. doi:10.1007/s10067-019-04671-6
  • Dong J, Yang H, Zhang Y, Hu Q. Triglyceride-glucose index is a predictive index of hyperuricemia events in elderly patients with hypertension: a cross-sectional study. Clin Exp Hypertens. 2022;44(1):34–39. doi:10.1080/10641963.2021.1984499
  • Yu C, Wang T, Zhou W, et al. Positive association between the triglyceride-glucose index and hyperuricemia in Chinese adults with hypertension: an insight from the China H-type hypertension registry study. Int J Endocrinol. 2022;2022:4272715. doi:10.1155/2022/4272715
  • Han R, Zhang Y, Jiang X. Relationship between four non-insulin-based indexes of insulin resistance and serum uric acid in patients with type 2 diabetes: a cross-sectional study. Diabetes Metab Syndr Obes. 2022;15:1461–1471. doi:10.2147/DMSO.S362248
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–S38. doi:10.2337/dc22-S002
  • Liu R, Zhang Q, Peng N, et al. Inverse correlation between serum irisin and cardiovascular risk factors among Chinese overweight/obese population. BMC Cardiovasc Disord. 2021;21(1):570. doi:10.1186/s12872-021-02380-0
  • Dai W, Ye L, Liu A, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine. 2017;96(39):e8179. doi:10.1097/MD.0000000000008179
  • Mazidi M, Katsiki N, Mikhailidis DP, Banach M. The link between insulin resistance parameters and serum uric acid is mediated by adiposity. Atherosclerosis. 2018;270:180–186. doi:10.1016/j.atherosclerosis.2017.12.033
  • Wu Y, He H, Yu K, et al. The association between serum uric acid levels and insulin resistance and secretion in prediabetes mellitus: a cross-sectional study. Ann Clin Lab Sci. 2019;49(2):218–223.
  • Li L, Shi Z, Ma L, Lu Y. Analysis of the correlation between plasma coagulation factor VII, PAI-1, and uric acid with insulin resistance and macrovascular complications in elderly patients with type 2 diabetes. Ann Palliat Med. 2021;10(1):664–671. doi:10.21037/apm-20-2609
  • Han T, Lan L, Qu R, et al. Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension. Hypertension. 2017;70(4):703–711. doi:10.1161/HYPERTENSIONAHA.117.09508
  • Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol. 2012;176(2):108–116. doi:10.1093/aje/kws002
  • Zhu Y, Hu Y, Huang T, et al. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun. 2014;447(4):707–714. doi:10.1016/j.bbrc.2014.04.080
  • McCormick N, O’Connor MJ, Yokose C, et al. Assessing the causal relationships between insulin resistance and hyperuricemia and gout using bidirectional Mendelian randomization. Arthritis Rheumatol. 2021;73(11):2096–2104. doi:10.1002/art.41779
  • Nakamura K, Sakurai M, Miura K, et al. HOMA-IR and the risk of hyperuricemia: a prospective study in non-diabetic Japanese men. Diabetes Res Clin Pract. 2014;106(1):154–160. doi:10.1016/j.diabres.2014.07.006
  • Toyoki D, Shibata S, Kuribayashi-Okuma E, et al. Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2. Am J Physiol Renal Physiol. 2017;313(3):F826–F834. doi:10.1152/ajprenal.00012.2017
  • Kottgen A, Albrecht E, Teumer A, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145–154. doi:10.1038/ng.2500
  • Furuhashi M, Matsumoto M, Murase T, et al. Independent links between plasma xanthine oxidoreductase activity and levels of adipokines. J Diabetes Investig. 2019;10(4):1059–1067. doi:10.1111/jdi.12982
  • Liu X, Chen Y, Boucher NL, Rothberg AE. Prevalence and change of central obesity among US Asian adults: NHANES 2011–2014. BMC Public Health. 2017;17(1):678. doi:10.1186/s12889-017-4689-6
  • Liu XZ, Li HH, Huang S, Zhao DB. Association between hyperuricemia and nontraditional adiposity indices. Clin Rheumatol. 2019;38(4):1055–1062. doi:10.1007/s10067-018-4374-x
  • Zong J, Sun Y, Zhang Y, et al. Correlation between serum uric acid level and central body fat distribution in patients with type 2 diabetes. Diabetes Metab Syndr Obes. 2020;13:2521–2531. doi:10.2147/DMSO.S260891
  • Zhang S, Huang YP, Li J, et al. The visceral-fat-area-to-hip-circumference ratio as a predictor for insulin resistance in a Chinese population with type 2 diabetes. Obes Facts. 2022;15(4):621–628. doi:10.1159/000525545
  • Sun H, Chang X, Bian N, et al. Adipose tissue insulin resistance is positively associated with serum uric acid levels and hyperuricemia in Northern Chinese adults. Front Endocrinol (Lausanne). 2022;13:835154. doi:10.3389/fendo.2022.835154
  • Dorio M, Bensenor IM, Lotufo P, Santos IS, Fuller R. Reference range of serum uric acid and prevalence of hyperuricemia: a cross-sectional study from baseline data of ELSA-Brasil cohort. Adv Rheumatol. 2022;62(1):15. doi:10.1186/s42358-022-00246-3
  • Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820. doi:10.1155/2015/762820
  • Kikuchi A, Kawamoto R, Ninomiya D, Kumagi T. Hyperuricemia is associated with all-cause mortality among males and females: findings from a study on Japanese community-dwelling individuals. Metabol Open. 2022;14:100186. doi:10.1016/j.metop.2022.100186
  • Xu JZ, Lu JL, Hu L, et al. Sex disparities in the association of serum uric acid with kidney stone: a cross-sectional study in China. Front Med. 2022;9:774351. doi:10.3389/fmed.2022.774351
  • Chen L, Wu L, Li Q, et al. Hyperuricemia associated with low skeletal muscle in the middle-aged and elderly population in China. Exp Clin Endocrinol Diabetes. 2022;130:546–553. doi:10.1055/a-1785-3729
  • Liu L, Lou S, Xu K, et al. Relationship between lifestyle choices and hyperuricemia in Chinese men and women. Clin Rheumatol. 2013;32(2):233–239. doi:10.1007/s10067-012-2108-z
  • Eljaaly Z, Mujammami M, Nawaz SS, Rafiullah M, Siddiqui K. Risk predictors of high uric acid levels among patients with type-2 diabetes. Diabetes Metab Syndr Obes. 2021;14:4911–4920. doi:10.2147/DMSO.S344894
  • Yu H, Zhao L, Liu L, et al. Relationship between serum uric acid level and nonalcoholic fatty liver disease in type 2 diabetes patients. Medicine. 2021;100(33):e26946. doi:10.1097/MD.0000000000026946
  • Zhang Y, Nie FQ, Huang XB, et al. High prevalence and low awareness of hyperuricemia in hypertensive patients among adults aged 50–79 years in Southwest China. BMC Cardiovasc Disord. 2022;22(1):2. doi:10.1186/s12872-021-02427-2
  • Qiu L, Cheng XQ, Wu J, et al. Prevalence of hyperuricemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provinces. BMC Public Health. 2013;13:664. doi:10.1186/1471-2458-13-664
  • Yang Y, Piao W, Huang K, et al. Dietary pattern associated with the risk of hyperuricemia in Chinese elderly: result from china nutrition and health surveillance 2015–2017. Nutrients. 2022;14(4):844.
  • Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on Bangladeshi adults. PLoS One. 2018;13(11):e0206850. doi:10.1371/journal.pone.0206850
  • Molla MD, Bekele A, Melka DS, et al. Hyperuricemia and its associated factors among adult staff members of the Ethiopian Public Health Institute, Ethiopia. Int J Gen Med. 2021;14:1437–1447. doi:10.2147/IJGM.S308158